ここから本文です

いつの間にかフェーズ3

Rakuten Aspyrian Enrolling Phase 3 Trial of ASP-1929 for Head and Neck Cancer
Rakuten Aspyrian
(PRNewsfoto/Aspyrian Therapeutics, Inc.)
NEWS PROVIDED BY
Rakuten Aspyrian, Inc.
Dec 17, 2018, 16:00 ET